Lichen sclerosus and atrophicus (LSA) most commonly affects the anogenital region. Extragenital involvement is rare, and women are reported to be affected 6 to 10 times more often than men. The aetiology of LSA is unclear, but genetic, physiological and environmental factors are thought to be involved. Several lines of evidence support the hypothesis of an autoimmune basis for LSA; an increased incidence of tissue-specific antibodies and an association with autoimmune disorders such as vitiligo, alopecia areata, thyroid disease and pernicious anaemia have been reported. We describe a paediatric patient with extragenital LSA associated with vitiligo who was successfully treated with topical steroids and retinoids.
Lichen sclerosus and atrophicus (LSA) is a chronic inflammatory dermatosis that predominantly affects the anogenital area, irrespective of age, sex or race, but is most commonly observed in prepubertal girls and postmenopausal women of Caucasian origin. Extragenital involvement is found in approximately II % of women and is rare in men (I). Extragenital involvement alone is uncommon and has been reported in about 6% of all women with LSA (2).
An II-year-old Caucasiangirl who had had vitiligo on the face, neck and arms for 4 years presented with ivory-white, round plaques on the back and abdomen (Fig. IA) . The lesions were asymptomatic and exhibited superficial sclerosis. There were no genital or oral lesions. Blood chemistry parameters and autoantibodies were normal.
Biopsy of an abdominal lesion showed findings suggestive of LSA, including epidermal atrophy, vacuolar degeneration of basal keratinocytes and a scarce dermo-epidermal inflammatory infiltrate. Two-week cycles of high-potency topical steroids (clobetasol propionate 0.05% once daily) alternated with 4 weeks of topical retinoids (retinaldehyde 0.05% once daily) led to progressive improvement of the lesions and to complete clearance in 3 months ( Fig. IB) .
Clinically, LSA is characterized by papules and plaques ofporcelain-white atrophic or thickened skin that may become purpuric, blistered or eroded. The genital lesions are pruritic whereas the extragenital ones, which usually arise on the inner thigh, submammary area, neck, shoulders and wrists, are asymptomatic (3). The aetiology of LSA is unclear, but genetic, physiological and environmental factors are thought to be involved.
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The decreased melanin production shared by LSA and vitiligo is probably due to an antigendriven immune reaction mediated by activated macrophages and clonally expanded T lymphocytes (7) . Loss of melanocytes may be due to the pathogenic connection between LSA and vitiligo; the lichenoid dermatitis seen in LSA could trigger an autoimmune reaction towards melanocytes and keratinocytes directed against altered cell antigens (8) .
We report the case of a paediatric patient with extragenital LSA associated with vitiligo that was successfully treated with topical steroids and retinoids.
The treatment of choice for LSA is based on high-potency corticosteroids such as c1obetasol propionate, which however appears to be less effecti ve towards extragenital lesions (9) . Topical steroids are associated with a risk of skin atrophy, which is particularly significant in childhood. Successful treatment with topical retinoids has also been reported (10) , especially for LSA unresponsive to ultrapotent topical steroids.
Topical retinoids have been shown to increase epidermal expression of CD44, which is considered as the principal hyaluronate cell-surface receptor ( II). Recent studies have demonstrated decreased or absent CD44 expression in LSA, with consequent hyaluronate accumulation in the superficial dermis associated with the typical dermal changes seen in LSA, explaining the role of topical retinoids in LSA treatment (12) . Retinoids have also been shown to prevent steroid-induced skin atrophy (13) , although prolonged treatment may give rise to cutaneous irritation, especially in the genital area ( I0).
In our patient alternate use of topical steroids and retinoids led to complete lesion clearance without adverse effects from either treatment. This is particularly important when treating children, where prolonged use of high -potency steroids is not recommended.
/ of tissue-specific antibodies and an association with autoimmune disorders such as vitiligo, alopecia areata, thyroid disease and pernicious anaemia have been reported (4) . Its frequent association with vitiligo, another disorder characterized by hypopigmented lesions, corroborates the hypothesis of a common autoimmune pathogenesis involving keratinocytes and melanocytes.
LSA hypopigmentation is believed to be underpinned by a block in melanosome transfer to keratinocytes, decreased melanin production and melanocyte loss (5) . A poss ible explanation for the former mechanism could be an altered keratinocyte phenotype preventing melanosome phagocytosis by keratinocytes (6) .
